Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,726 | 25 | 55.1% |
| Travel and Lodging | $1,404 | 3 | 44.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intersect ENT, Inc. | $2,083 | 9 | $0 (2019) |
| Stryker Corporation | $306.68 | 1 | $0 (2018) |
| Optinose US, Inc. | $297.45 | 8 | $0 (2021) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2020) |
| Spirox Inc | $124.54 | 1 | $0 (2017) |
| Medtronic, Inc. | $81.16 | 2 | $0 (2023) |
| Ethicon US, LLC | $33.16 | 1 | $0 (2019) |
| PFIZER INC. | $29.70 | 2 | $0 (2024) |
| Smith+Nephew, Inc. | $20.42 | 1 | $0 (2019) |
| Acclarent, Inc | $19.63 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.70 | 2 | PFIZER INC. ($29.70) |
| 2023 | $63.34 | 1 | Medtronic, Inc. ($63.34) |
| 2022 | $17.82 | 1 | Medtronic, Inc. ($17.82) |
| 2021 | $64.33 | 3 | Optinose US, Inc. ($54.03) |
| 2020 | $194.50 | 4 | GENZYME CORPORATION ($125.00) |
| 2019 | $120.51 | 5 | OptiNose US, Inc. ($41.98) |
| 2018 | $456.61 | 3 | Stryker Corporation ($306.68) |
| 2017 | $2,184 | 9 | Intersect ENT, Inc. ($2,040) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2023 | Medtronic, Inc. | STEALTHSTATION S8 PLATFORM (Device) | Food and Beverage | In-kind items and services | $63.34 | General |
| Category: Image Guided Surgery Products | ||||||
| 07/06/2022 | Medtronic, Inc. | SINUVA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/21/2021 | Forte Bio-Pharma LLC | PROLATE (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: Pain | ||||||
| 02/16/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/01/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/05/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/24/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/15/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/29/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 11/22/2019 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/28/2019 | Smith+Nephew, Inc. | Coblation - Turbinate Wands (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: ENT | ||||||
| 05/06/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 01/16/2019 | Ethicon US, LLC | HARMONIC Product Family (Device), Enseal X1 5mm, ENSEAL Product Family | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: Energy | ||||||
| 10/31/2018 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $131.94 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/16/2018 | Stryker Corporation | ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $306.68 | General |
| Category: ENTELLUS | ||||||
| 08/13/2018 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/13/2017 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Otolaryngology | ||||||
| 10/27/2017 | Intersect ENT, Inc. | PROPEL (Device) | Travel and Lodging | Cash or cash equivalent | $887.40 | General |
| Category: Otolaryngology | ||||||
| 10/27/2017 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $498.07 | General |
| Category: Otolaryngology | ||||||
| 10/27/2017 | Intersect ENT, Inc. | PROPEL (Device) | Travel and Lodging | Cash or cash equivalent | $372.61 | General |
| Category: Otolaryngology | ||||||
| 10/27/2017 | Intersect ENT, Inc. | PROPEL (Device) | Travel and Lodging | Cash or cash equivalent | $144.37 | General |
| Category: Otolaryngology | ||||||
| 10/26/2017 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $106.61 | General |
| Category: Otolaryngology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 536 | 622 | $339,447 | $63,908 |
| 2022 | 11 | 675 | 832 | $360,669 | $88,660 |
| 2021 | 9 | 546 | 671 | $305,453 | $79,221 |
| 2020 | 8 | 361 | 440 | $201,727 | $43,109 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 124 | $64,404 | $14,801 | 23.0% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 75 | 96 | $68,569 | $12,127 | 17.7% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 47 | 55 | $57,973 | $9,660 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 90 | 90 | $45,870 | $9,128 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 74 | $29,038 | $5,839 | 20.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 106 | 126 | $37,714 | $4,830 | 12.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $22,519 | $4,721 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $8,282 | $1,874 | 22.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $5,078 | $928.77 | 18.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 100 | 138 | $67,758 | $17,398 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 132 | $55,044 | $16,008 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $37,178 | $9,081 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 92 | 92 | $40,940 | $8,742 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 99 | $30,789 | $7,903 | 25.7% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 37 | 44 | $41,536 | $7,252 | 17.5% |
| 30903 | Complex control of nose bleed | Office | 2022 | 17 | 24 | $19,725 | $6,307 | 32.0% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 140 | 176 | $32,560 | $6,290 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 39 | $19,851 | $6,251 | 31.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $10,472 | $2,460 | 23.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $4,816 | $969.80 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 125 | $52,125 | $15,427 | 29.6% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 89 | 114 | $55,860 | $14,170 | 25.4% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 39 | 52 | $49,036 | $10,279 | 21.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 64 | 64 | $41,024 | $10,081 | 24.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 44 | $22,396 | $8,062 | 36.0% |
About Dr. David Arnstein, MD
Dr. David Arnstein, MD is a Pediatric Otolaryngology healthcare provider based in Los Gatos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801898796.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Arnstein, MD has received a total of $3,131 in payments from pharmaceutical and medical device companies, with $29.70 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,726).
As a Medicare-enrolled provider, Arnstein has provided services to 2,118 Medicare beneficiaries, totaling 2,565 services with total Medicare billing of $274,899. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Pediatric Otolaryngology
- Other Specialties Otolaryngology
- Location Los Gatos, CA
- Active Since 08/11/2005
- Last Updated 04/29/2024
- Taxonomy Code 207YP0228X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801898796
Products in Payments
- PROPEL (Device) $2,083
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $306.68
- Xhance (Drug) $297.45
- DUPIXENT (Biological) $125.00
- Latera (Device) $124.54
- STEALTHSTATION S8 PLATFORM (Device) $63.34
- HARMONIC Product Family (Device) $33.16
- ELIQUIS (Drug) $29.70
- Coblation - Turbinate Wands (Device) $20.42
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $19.63
- SINUVA (Drug) $17.82
- PROLATE (Drug) $10.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.